PKP2 and arrhythmogenic right ventricular cardiomyopathy: Studies in cell culture systems and in tissue from ARVC-affected patients have previously indicated that loss of expression or mutations in PKP2 can alter the structure and function of gap junctions (Oxford et al., 2007; Saffitz, 2009; Asimaki and Saffitz, 2014).